Our top pick for
Veeva Systems Inc is a health information services business based in the US. Veeva Systems shares (VEEV) are listed on the NYSE and all prices are listed in US Dollars. Veeva Systems employs 3,501 staff and has a trailing 12-month revenue of around USD$1.3 billion.
|Latest market close||USD$306.27|
|52-week range||USD$118.11 - USD$313.99|
|50-day moving average||USD$281.5506|
|200-day moving average||USD$238.2086|
|Wall St. target price||USD$303.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$2.061|
|1 week (2021-01-06)||N/A|
|1 month (2020-12-13)||N/A|
|3 months (2020-10-16)||306.27|
|6 months (2020-07-17)||22.36%|
|1 year (2020-01-13)||N/A|
|2 years (2019-01-13)||N/A|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-13)||N/A|
Valuing Veeva Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Veeva Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Veeva Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 149x. In other words, Veeva Systems shares trade at around 149x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Veeva Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.3055. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Veeva Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Veeva Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$347.4 million.
The EBITDA is a measure of a Veeva Systems's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.3 billion|
|Operating margin TTM||24.95%|
|Gross profit TTM||USD$800.7 million|
|Return on assets TTM||9.14%|
|Return on equity TTM||19.32%|
|Market capitalisation||USD$46.2 billion|
TTM: trailing 12 months
There are currently 1.9 million Veeva Systems shares held short by investors – that's known as Veeva Systems's "short interest". This figure is 4.7% down from 2.0 million last month.
There are a few different ways that this level of interest in shorting Veeva Systems shares can be evaluated.
Veeva Systems's "short interest ratio" (SIR) is the quantity of Veeva Systems shares currently shorted divided by the average quantity of Veeva Systems shares traded daily (recently around 825261.40350877). Veeva Systems's SIR currently stands at 2.28. In other words for every 100,000 Veeva Systems shares traded daily on the market, roughly 2280 shares are currently held short.
However Veeva Systems's short interest can also be evaluated against the total number of Veeva Systems shares, or, against the total number of tradable Veeva Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Veeva Systems's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Veeva Systems shares in existence, roughly 10 shares are currently held short) or 0.0139% of the tradable shares (for every 100,000 tradable Veeva Systems shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Veeva Systems.
Find out more about how you can short Veeva Systems stock.
We're not expecting Veeva Systems to pay a dividend over the next 12 months.
Over the last 12 months, Veeva Systems's shares have ranged in value from as little as $118.11 up to $313.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Veeva Systems's is 0.9035. This would suggest that Veeva Systems's shares are less volatile than average (for this exchange).
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. Veeva Systems has collaboration with RedHill Biopharma Ltd. to enhance value of Opaganib Phase 2/3 COVID-19 clinical data. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.